Wealthsource Partners, LLC Novartis Ag Transaction History

Wealthsource Partners, LLC

$1.52 Billion
Q4 2023

A detailed history of Wealthsource Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealthsource Partners, LLC holds 4,936 shares of NVS stock, worth $562,457. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,936

Previous 5,561 11.24%

Holding current value

$562,457

Previous $566,000 12.01%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$92.27 - $101.54 $57,668 - $63,462	-625 Reduced 11.24%	4,936 $498,000
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $5,778 - $6,412	-61 Reduced 1.09%	5,561 $566,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $345,192 - $391,419	-3,731 Reduced 39.89%	5,622 $567,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $4,801 - $5,568	-60 Reduced 0.64%	9,353 $860,000
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $381,754 - $467,503	5,053 Added 115.89%	9,413 $853,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $174,885 - $204,537	-2,344 Reduced 34.96%	4,360 $331,000
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $93,000 - $108,281	-1,155 Reduced 14.7%	6,704 $567,000
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $24,834 - $28,092	-310 Reduced 3.79%	7,859 $690,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $20,881 - $23,090	262 Added 3.31%	8,169 $715,000
Q3 2021 Nov 18, 2021	BUY	$81.78 - $95.14 $4,089 - $4,757	50 Added 0.64%	7,907 $647,000
Q2 2021 Nov 18, 2021	SELL	$85.24 - $94.15 $129,138 - $142,637	-1,515 Reduced 16.17%	7,857 $717,000
Q1 2021 Jun 21, 2021	SELL	$83.5 - $98.47 $29,141 - $34,366	-349 Reduced 3.59%	9,372 $801,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $1,951 - $2,360	-25 Reduced 0.26%	9,721 $918,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $47,723 - $52,871	-581 Reduced 5.63%	9,746 $847,000
Q2 2020 Aug 17, 2020	BUY	$80.93 - $91.1 $99,867 - $112,417	1,234 Added 13.57%	10,327 $902,000
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $102,047 - $142,970	1,444 Added 18.88%	9,093 $750,000
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $421,918 - $477,040	5,002 Added 188.97%	7,649 $724,000
Q3 2019 Nov 15, 2019	SELL	$85.54 - $94.26 $24,122 - $26,581	-282 Reduced 9.63%	2,647 $230,000
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $22,092 - $27,190	-293 Reduced 9.09%	2,929 $267,000
Q1 2018 Apr 16, 2018	BUY	$70.39 - $84.15 $27,240 - $32,566	387 Added 13.65%	3,222 $239,000
Q4 2017 Feb 16, 2018	BUY	$72.33 - $77.64 $12,947 - $13,897	179 Added 6.74%	2,835 $238,000
Q3 2017 Nov 20, 2017	SELL	$74.14 - $77.27 $18,238 - $19,008	-246 Reduced 8.48%	2,656 $228,000
Q2 2017 Aug 16, 2017	BUY	N/A	2,902	2,902 $242,000

Others Institutions Holding NVS

# of Institutions

1,425

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $245B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.

Account

Wealthsource Partners, LLC Novartis Ag Transaction History